ELERAXI
LIVE

Serial Number

79247191

Owner

NOVARTIS AG

Filing Date

Sep 26, 2018

Add to watchlist:

No watchlists yet
View on USPTO

ELERAXI Trademark

Serial Number: 79247191 • Registration: 5736661

ELERAXI is a trademark filed by NOVARTIS AG on September 26, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

September 26, 2018

Registration Date

April 30, 2019

Published for Opposition

February 12, 2019

Cancellation Date

February 14, 2022

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Sep 10, 2022 DENC
DEATH OF INTERNATIONAL REGISTRATION
Sep 10, 2022 DETH
NOTIFICATION PROCESSED BY IB
Jul 5, 2019 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Jun 17, 2019 FICS
FINAL DISPOSITION PROCESSED
Jun 17, 2019 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
May 30, 2019 GPAR
REGISTERED-PRINCIPAL REGISTER
Apr 30, 2019 R.PR
PUBLISHED FOR OPPOSITION
Feb 12, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Feb 8, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 23, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 23, 2019 OP2R
NOTICE OF PUBLICATION
Jan 23, 2019 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 4, 2019 CNSA
ASSIGNED TO EXAMINER
Jan 3, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 18, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 14, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 10, 2018 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Dec 6, 2018 SDRC